ADPKD

Open Access
A Patient Perspective on Genetic Testing for ADPKD
Dwight Odland

CJASN July 2020, CJN.14051119; DOI: https://doi.org/10.2215/CJN.14051119

Add to Selected Citations
You have accessRestricted Access
Urinary Lithogenic Risk Profile in ADPKD Patients Treated with Tolvaptan
Matteo Bargagli, Nasser A. Dhayat, Manuel Anderegg, Mariam Semmo, Uyen Huynh-Do, Bruno Vogt, Pietro Manuel Ferraro and Daniel G. Fuster

CJASN July 2020, 15 (7) 1007-1014; DOI: https://doi.org/10.2215/CJN.13861119

Add to Selected Citations
You have accessRestricted Access
A Post Hoc Analysis of Statin Use in Tolvaptan Autosomal Dominant Polycystic Kidney Disease Pivotal Trials
Susan E. Shoaf, John Ouyang, Olga Sergeyeva, Alvin Estilo, Hui Li and Deborah Leung

CJASN May 2020, 15 (5) 643-650; DOI: https://doi.org/10.2215/CJN.08170719

Add to Selected Citations
You have accessRestricted Access
Epidemiology of Autosomal Dominant Polycystic Kidney Disease in Olmsted County
Tatsuya Suwabe, Shehbaz Shukoor, Alanna M. Chamberlain, Jill M. Killian, Bernard F. King, Marie Edwards, Sarah R. Senum, Charles D. Madsen, Fouad T. Chebib, Marie C. Hogan, Emilie Cornec-Le Gall, Peter C. Harris and Vicente E. Torres

CJASN January 2020, 15 (1) 69-79; DOI: https://doi.org/10.2215/CJN.05900519

Add to Selected Citations
Open Access
Presymptomatic Screening for Intracranial Aneurysms in Patients with Autosomal Dominant Polycystic Kidney Disease
Irina M. Sanchis, Shehbaz Shukoor, Maria V. Irazabal, Charles D. Madsen, Fouad T. Chebib, Marie C. Hogan, Ziad El-Zoghby, Peter C. Harris, John Huston, Robert D. Brown and Vicente E. Torres

CJASN August 2019, 14 (8) 1151-1160; DOI: https://doi.org/10.2215/CJN.14691218

Add to Selected Citations
You have accessRestricted Access
Screening for Intracranial Aneurysms in Patients with Autosomal Dominant Polycystic Kidney Disease
Adrien Flahault and Dominique Joly

CJASN August 2019, 14 (8) 1242-1244; DOI: https://doi.org/10.2215/CJN.02100219

Add to Selected Citations
You have accessRestricted Access
Growth Pattern of Kidney Cyst Number and Volume in Autosomal Dominant Polycystic Kidney Disease
Kyongtae T. Bae, Wen Zhou, Chengli Shen, Douglas P. Landsittel, Zhiyuan Wu, Cheng Tao, Arlene B. Chapman, Vicente E. Torres, Alan S.L. Yu, Michal Mrug, William M. Bennett, Peter C. Harris and for the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP)

CJASN June 2019, 14 (6) 823-833; DOI: https://doi.org/10.2215/CJN.10360818

Add to Selected Citations
You have accessRestricted Access
Kidney Function Reserve Capacity in Early and Later Stage Autosomal Dominant Polycystic Kidney Disease
A. Lianne Messchendorp, Marco van Londen, Jacob M. Taylor, Martin H. de Borst, Gerjan Navis, Niek F. Casteleijn, Carlo A.J.M. Gaillard, Stephan J.L. Bakker, Ron T. Gansevoort and on behalf of the DIPAK Consortium

CJASN November 2018, 13 (11) 1680-1692; DOI: https://doi.org/10.2215/CJN.03650318

Add to Selected Citations
You have accessRestricted Access
Recent Advances in the Management of Autosomal Dominant Polycystic Kidney Disease
Fouad T. Chebib and Vicente E. Torres

CJASN November 2018, 13 (11) 1765-1776; DOI: https://doi.org/10.2215/CJN.03960318

Add to Selected Citations
You have accessRestricted Access
Vascular Dysfunction, Oxidative Stress, and Inflammation in Autosomal Dominant Polycystic Kidney Disease
Kristen L. Nowak, Wei Wang, Heather Farmer-Bailey, Berenice Gitomer, Mikaela Malaczewski, Jelena Klawitter, Anna Jovanovich and Michel Chonchol

CJASN October 2018, 13 (10) 1493-1501; DOI: https://doi.org/10.2215/CJN.05850518

Add to Selected Citations

Main menu

User menu

Search

ADPKD

Pages

About

Author Information

More information